COMMUNIQUÉS West-GlobeNewswire

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
13/02/2025
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 27, 2025 at 4:00 PM Eastern Time [...]
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
13/02/2025
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period and [...]
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
13/02/2025
Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 13, 2025 . Sanofi announces today the filing of its Form 20-F with the U.S. [...]
Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
13/02/2025
Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris, le 13 février 2025 . Sanofi annonce avoir déposé son Document d’Enregistrement Universel [...]
The Shift Towards Proactive Health: Biologic Pharmamedical Stands Firm Amidst Tariffs and Big Pharma Shakeup
13/02/2025
RICHMOND, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- As the healthcare and supplement industries experience seismic shifts—driven by new U.S. tariffs, growing scrutiny on Big Pharma, and rising pharmaceutical [...]
Over 120 Epilepsy Organizations Applaud the Introduction of the National Plan for Epilepsy Act in Congress
13/02/2025
The National Plan aims to support the 3.4 million people living with epilepsy in the United States through a unified approach, calling for bipartisan support. BOWIE, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Epilepsy [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025
13/02/2025
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2025
13/02/2025
Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
Merus fera une présentation lors du Citi's 2025 Virtual Oncology Leadership Summit
13/02/2025
UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 13 févr. 2025 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq : MRUS), une société d’oncologie au stade clinique développant des anticorps de pleine longueur multispécifiques et [...]
Ultimovacs ASA: Cancellation of subsequent repair offering
13/02/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. [...]
Nutrify Today C-Suite Sumflex 2025 Shaping the Future of Nutraceuticals
13/02/2025
MUMBAI, India, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Nutrify Today will host C-Suite Sumflex 2025 on May 8-9, at the Trident and Oberoi Hotels in Mumbai, bringing together industry leaders, investors, and policymakers to [...]
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
13/02/2025
Press Release – No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results Copenhagen, Denmark, February 13, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: [...]
LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
13/02/2025
PASADENA, CALIF., Feb. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced the closing of its [...]
Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
13/02/2025
- Disease control rate (DCR) of 78% (7 of 9) in combination escalation arm of MDNA11 with Merck’s (known as MSD outside of Canada and the US) KEYTRUDA ® (pembrolizumab) in ongoing Phase 1/2 ABILITY-1 trial including one [...]
USOSM Expands Best-in-Class Network of Premier Oral and Maxillofacial Surgeons
13/02/2025
Secures New Partner Practices on East and West Coasts IRVING, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) is pleased to announce new partnerships with three premier oral and [...]
Author Andrew Leland Receives 2025 Helen Keller Achievement Award
13/02/2025
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) is pleased to announce author Andrew Leland will be among those to receive the prestigious Helen Keller Achievement Award, which [...]
Idorsia publishes the resolutions for the upcoming bondholder meeting
12/02/2025
Ad hoc announcement pursuant to Art. 53 LR The updated invitation to the bondholder meeting – scheduled for February 25, 2025 – sets out the terms of the resolutions to be voted upon Unaudited Financial Status as of [...]
Illuccix® Approved in the United Kingdom
12/02/2025
MELBOURNE, Australia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory [...]
Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit
12/02/2025
VANCOUVER, British Columbia and SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today [...]

Pages